VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
OVID
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
OVIDOvid Therapeutics Inc.
$2.57$480M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksOVIDQuarterly Balance Sheet

Ovid Therapeutics Inc. (OVID) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Ovid Therapeutics Inc. (OVID) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

OVID Balance Sheet

Quarterly statement

OVID Balance Sheet

Ovid Therapeutics Inc. (OVID) balance sheet — 12-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets123.62M160.15M90.45M28.82M42.09M45.92M55.94M65.83M80.89M93.17M109.6M91.71M102.17M119.52M131.38M140.5M156.08M170.09M190.48M205.06M
Cash & Short-Term Investments117.22M155.52M69.64M25.6M38.35M43M53.08M62.71M76.97M90.26M105.83M87.07M96.52M117.72M129M137.86M152.37M166.67M187.8M201.78M
Cash Only11.33M94.06M13.15M20.61M28.41M21.14M26.3M15.02M29.69M30.77M27.04M57.44M71.62M63.05M129M58.26M72.81M166.67M187.8M201.78M
Short-Term Investments105.89M61.46M56.48M4.99M9.93M21.86M26.77M47.7M47.28M59.49M78.79M29.64M24.89M54.67M079.6M79.55M000
Accounts Receivable00000000000000000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets04.62M20.81M3.22M00003.92M01K001.8M2.38M01M1M2.68M0
Total Non-Current Assets108.36M65.48M60.49M35.02M35.34M35.73M36.23M36.83M37.2M38.44M34.43M33.32M34.06M23.85M23.89M24.53M21.25M21.01M4.07M2.03M
Property, Plant & Equipment11.18M11.52M012.19M12.5M12.86M13.23M13.59M13.97M14.31M14.66M15.01M15.37M15.72M16.07M16.34M16.68M15.95M242.76K104.7K
Fixed Asset Turnover0.06x--0.01x0.49x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.00x0.00x0.00x0.00x-0.18x--
Goodwill00000000000000-39.09K00000
Intangible Assets0000038K92K155K219K148K200K222.05K263.37K185.91K261.19K275.45K328.8K244.03K164K197.15K
Long-Term Investments95.24M41.96M64.7M20.91M20.91M20.91M20.97M21.13M22.98M22.02M17.63M16.12M16.47M7.91M5.62M5.95M2.23M2.78M3.56M1.63M
Other Non-Current Assets1.93M12.01M-4.22M1.93M1.93M1.93M1.93M1.96M27K1.96M1.94M1.96M1.96M26.6K1.97M1.97M2.01M2.03M96.13K96.03K
Total Assets231.97M225.63M150.93M63.85M77.43M81.65M92.17M102.65M118.09M131.61M144.03M125.03M136.23M143.37M155.27M165.03M177.33M191.1M194.54M207.09M
Asset Turnover0.00x-0.01x0.00x0.08x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x-0.01x--
Asset Growth %199.6%176.32%63.76%-37.8%-34.43%-37.96%-36.01%-17.9%-13.31%-8.2%-7.24%-24.24%-23.18%-24.98%-20.19%-20.31%-18.66%-19.52%156.23%126.08%
Total Current Liabilities9.98M15.75M8.29M6.8M8.92M9.31M10.52M11.63M14.12M8.9M11.47M8.66M10.14M6.72M6.99M6.73M9.22M10.23M14.8M10.06M
Accounts Payable4.07M8.88M1.96M1.71M3.95M1.95M3.19M2.71M4.72M3.6M3.7M1.22M3.76M1.83M1.95M1.03M4.62M2.26M7.13M3.14M
Days Payables Outstanding-13.93K----------------8.31K-
Short-Term Debt01.46M0000001.29M0000804.14K000000
Deferred Revenue (Current)000718K0000000000000000
Other Current Liabilities05.41M1.79M0718K01K03.16M10002.19M0284.54K003.91M1.56M
Current Ratio12.39x10.17x10.91x4.24x4.72x4.93x5.32x5.66x5.73x10.47x9.55x10.59x10.07x17.78x18.79x20.87x16.94x16.63x12.87x20.37x
Quick Ratio12.39x10.17x10.91x4.24x4.72x4.93x5.32x5.66x5.73x10.47x9.55x10.59x10.07x17.78x18.79x20.87x16.94x16.63x12.87x20.37x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities12.1M11.61M11.99M12.35M12.71M13.07M13.42M14.73M15.07M44.43M44.76M15.07M15.39M15.7M16M16.25M15.97M15.87M00
Long-Term Debt00000000972K00000000000
Capital Lease Obligations11.23M011.99M12.35M12.71M13.07M13.42M13.76M14.1M14.43M14.76M15.07M15.39M15.7M16M16.25M15.97M15.87M00
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities872K11.61M0001K0972K030M30M000000000
Total Liabilities22.08M27.36M20.27M19.15M21.64M22.38M23.94M26.36M29.19M53.33M56.23M23.74M25.53M22.42M22.99M22.98M25.18M26.1M14.8M10.06M
Total Debt12.71M1.46M13.42M13.76M14.1M14.43M14.76M15.07M16.36M15.7M16M16.3M16.33M16.5M16.54M16.25M15.97M15.87M00
Net Debt1.39M-92.61M266K-6.85M-14.32M-6.71M-11.55M58K-13.33M-15.07M-11.04M-41.14M-55.29M-46.55M-112.47M-42.01M-56.84M-150.8M-187.8M-201.78M
Debt / Equity0.06x0.01x0.10x0.31x0.25x0.24x0.22x0.20x0.18x0.20x0.18x0.16x0.15x0.14x0.13x0.11x0.10x0.10x--
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--------------------
Total Equity209.89M198.27M130.66M44.7M55.79M59.28M68.23M76.29M88.9M78.28M87.8M101.29M110.7M120.95M132.27M142.05M152.15M165M179.75M197.02M
Equity Growth %276.22%234.48%91.51%-41.41%-37.25%-24.28%-22.29%-24.68%-19.69%-35.28%-33.62%-28.69%-27.24%-26.7%-26.41%-27.9%-26.4%-25.38%311.96%209.57%
Book Value per Share2.852.691.600.630.780.830.961.071.251.111.241.431.571.721.882.022.162.352.642.90
Total Shareholders' Equity209.89M198.27M130.66M44.7M55.79M59.28M68.23M76.29M88.9M78.28M87.8M101.29M110.7M120.95M132.27M142.05M152.15M165M179.75M197.02M
Common Stock185K167K130K71K71K71K71K71K71K71K71K70.68K70.6K70.49K70.47K70.47K70.41K70.37K70.36K68.02K
Retained Earnings-353.71M-338.7M-321.71M-331.38M-319.22M-314.53M-304.3M-295.05M-281.04M-289.56M-277.87M-262.54M-251.29M-238.88M-225.53M-214.02M-202.05M-187.47M-171.36M-145.36M
Treasury Stock00000000000000000000
Accumulated OCI-750K-422K-202K-126K-69K-48K-35K36K-12K-19K0-3.88K5.21K5.63K-42.19K-82.79K-90.13K000
Minority Interest00000000000000000000